Copyright
©The Author(s) 2025.
World J Gastrointest Surg. Apr 27, 2025; 17(4): 100821
Published online Apr 27, 2025. doi: 10.4240/wjgs.v17.i4.100821
Published online Apr 27, 2025. doi: 10.4240/wjgs.v17.i4.100821
Table 3 Levels of the intestinal microbiota, mean ± SD, CFU/g
Group | Case | Before, Lactobacillus acidophilus | After, Lactobacillus acidophilus | Before, Bifidocaterium | After, Bifidocaterium | Before, Escherichia coli | After, Escherichia coli | Before, Enterococcus faecalis | After, Enterococcus faecalis |
Control | 40 | 6.32 ± 0.56 | 6.92 ± 0.48a | 7.54 ± 0.52 | 8.21 ± 0.44a | 10.27 ± 1.18 | 8.72 ± 0.80a | 8.18 ± 0.82 | 7.12 ± 0.68a |
Observation | 40 | 6.35 ± 0.52 | 7.54 ± 0.42a | 7.48 ± 0.56 | 9.12 ± 0.42a | 10.21 ± 1.24 | 7.32 ± 0.64a | 8.21 ± 0.78 | 6.08 ± 0.54a |
t | 0.248 | 6.148 | 0.497 | 9.462 | 0.222 | 8.643 | 0.168 | 7.575 | |
P value | 0.805 | < 0.001 | 0.621 | < 0.001 | 0.825 | < 0.001 | 0.867 | < 0.001 |
- Citation: Lu H, Wu WD, Ji L, Xu XY. Effects of Bifidobacterium triple viable bacteria-assisted mirtazapine in managing depression in patients after radical surgery for gastric cancer. World J Gastrointest Surg 2025; 17(4): 100821
- URL: https://www.wjgnet.com/1948-9366/full/v17/i4/100821.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i4.100821